Clearly a lack of respect to investors and clearly not enough management experience to sustain trust with the long term share holders. Lack of clarity in communications and short falls in effectively communicating through PR's or interviews. If restructuring is advancing; if funding plans are changing.. and if drug testing is advancing; is what anyone that is long here wants to know. If this was clearly communicated perhaps we'd have more funds being invested and less anger and frustration on these boards.
News 
Market Data 
Discover 
AI
